vs

Side-by-side financial comparison of AGENUS INC (AGEN) and First Foundation Inc. (FFWM). Click either name above to swap in a different company.

First Foundation Inc. is the larger business by last-quarter revenue ($48.4M vs $34.2M, roughly 1.4× AGENUS INC). AGENUS INC runs the higher net margin — -31.0% vs -97.9%, a 66.8% gap on every dollar of revenue. On growth, First Foundation Inc. posted the faster year-over-year revenue change (421.7% vs 27.5%). Over the past eight quarters, AGENUS INC's revenue compounded faster (10.5% CAGR vs -2.7%).

Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.

John B. Lacson Colleges Foundation (Bacolod), Inc. is a private maritime college in Bacolod, Negros Occidental, Philippines.

AGEN vs FFWM — Head-to-Head

Bigger by revenue
FFWM
FFWM
1.4× larger
FFWM
$48.4M
$34.2M
AGEN
Growing faster (revenue YoY)
FFWM
FFWM
+394.2% gap
FFWM
421.7%
27.5%
AGEN
Higher net margin
AGEN
AGEN
66.8% more per $
AGEN
-31.0%
-97.9%
FFWM
Faster 2-yr revenue CAGR
AGEN
AGEN
Annualised
AGEN
10.5%
-2.7%
FFWM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AGEN
AGEN
FFWM
FFWM
Revenue
$34.2M
$48.4M
Net Profit
$-10.6M
$-8.0M
Gross Margin
Operating Margin
42.1%
-97.5%
Net Margin
-31.0%
-97.9%
Revenue YoY
27.5%
421.7%
Net Profit YoY
77.3%
43.0%
EPS (diluted)
$0.09
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGEN
AGEN
FFWM
FFWM
Q4 25
$34.2M
$48.4M
Q3 25
$30.2M
$63.6M
Q2 25
$25.7M
$51.4M
Q1 25
$24.1M
$71.4M
Q4 24
$26.8M
$9.3M
Q3 24
$25.1M
$9.2M
Q2 24
$23.5M
$57.5M
Q1 24
$28.0M
$51.1M
Net Profit
AGEN
AGEN
FFWM
FFWM
Q4 25
$-10.6M
$-8.0M
Q3 25
$63.9M
$-146.3M
Q2 25
$-30.0M
$-7.7M
Q1 25
$-26.4M
$6.9M
Q4 24
$-46.8M
$-14.1M
Q3 24
$-67.2M
$-82.2M
Q2 24
$-54.8M
$3.1M
Q1 24
$-63.5M
$793.0K
Gross Margin
AGEN
AGEN
FFWM
FFWM
Q4 25
Q3 25
97.9%
Q2 25
99.1%
Q1 25
99.4%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
99.5%
Q1 24
99.6%
Operating Margin
AGEN
AGEN
FFWM
FFWM
Q4 25
42.1%
-97.5%
Q3 25
-15.0%
-92.7%
Q2 25
-65.0%
-21.1%
Q1 25
-55.3%
8.8%
Q4 24
-96.5%
-247.7%
Q3 24
-125.5%
-1276.7%
Q2 24
-128.4%
4.6%
Q1 24
-117.4%
-0.2%
Net Margin
AGEN
AGEN
FFWM
FFWM
Q4 25
-31.0%
-97.9%
Q3 25
211.4%
-230.1%
Q2 25
-116.8%
-15.0%
Q1 25
-109.6%
9.7%
Q4 24
-174.4%
-152.2%
Q3 24
-267.7%
-896.9%
Q2 24
-233.1%
5.4%
Q1 24
-226.6%
1.6%
EPS (diluted)
AGEN
AGEN
FFWM
FFWM
Q4 25
$0.09
$-0.09
Q3 25
$1.94
$-1.78
Q2 25
$-1.00
$-0.09
Q1 25
$-1.03
$0.08
Q4 24
$-1.95
$-0.24
Q3 24
$-3.08
$-1.23
Q2 24
$-2.52
$0.05
Q1 24
$-3.04
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGEN
AGEN
FFWM
FFWM
Cash + ST InvestmentsLiquidity on hand
$3.0M
$1.6B
Total DebtLower is stronger
$44.7M
Stockholders' EquityBook value
$-271.1M
$912.6M
Total Assets
$226.8M
$11.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGEN
AGEN
FFWM
FFWM
Q4 25
$3.0M
$1.6B
Q3 25
$3.5M
$1.7B
Q2 25
$9.5M
$1.1B
Q1 25
$18.5M
$1.0B
Q4 24
$40.4M
$1.0B
Q3 24
$44.8M
$1.1B
Q2 24
$93.7M
$1.4B
Q1 24
$52.9M
$1.6B
Total Debt
AGEN
AGEN
FFWM
FFWM
Q4 25
$44.7M
Q3 25
$34.2M
Q2 25
$33.9M
Q1 25
$33.6M
Q4 24
$33.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AGEN
AGEN
FFWM
FFWM
Q4 25
$-271.1M
$912.6M
Q3 25
$-274.1M
$917.9M
Q2 25
$-354.6M
$1.1B
Q1 25
$-341.8M
$1.1B
Q4 24
$-326.4M
$1.1B
Q3 24
$-292.3M
$1.1B
Q2 24
$-241.3M
$933.2M
Q1 24
$-201.4M
$928.7M
Total Assets
AGEN
AGEN
FFWM
FFWM
Q4 25
$226.8M
$11.9B
Q3 25
$233.9M
$11.9B
Q2 25
$185.2M
$11.6B
Q1 25
$200.2M
$12.6B
Q4 24
$226.3M
$12.6B
Q3 24
$238.5M
$13.4B
Q2 24
$292.4M
$13.7B
Q1 24
$256.6M
$13.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGEN
AGEN
FFWM
FFWM
Operating Cash FlowLast quarter
$-16.6M
$-31.9M
Free Cash FlowOCF − Capex
$-35.2M
FCF MarginFCF / Revenue
-72.8%
Capex IntensityCapex / Revenue
0.0%
6.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-45.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGEN
AGEN
FFWM
FFWM
Q4 25
$-16.6M
$-31.9M
Q3 25
$-14.7M
$9.2M
Q2 25
$-20.2M
$-16.3M
Q1 25
$-25.6M
$-552.0K
Q4 24
$-28.7M
$-8.7M
Q3 24
$-53.3M
$14.2M
Q2 24
$-38.2M
$-9.1M
Q1 24
$-38.2M
$7.2M
Free Cash Flow
AGEN
AGEN
FFWM
FFWM
Q4 25
$-35.2M
Q3 25
$8.6M
Q2 25
$-20.2M
$-16.7M
Q1 25
$-25.6M
$-2.5M
Q4 24
$-28.7M
$-11.4M
Q3 24
$-53.3M
$13.4M
Q2 24
$-38.6M
$-9.4M
Q1 24
$-38.2M
$5.9M
FCF Margin
AGEN
AGEN
FFWM
FFWM
Q4 25
-72.8%
Q3 25
13.5%
Q2 25
-78.7%
-32.4%
Q1 25
-106.5%
-3.5%
Q4 24
-107.0%
-123.5%
Q3 24
-212.2%
146.2%
Q2 24
-164.4%
-16.3%
Q1 24
-136.5%
11.6%
Capex Intensity
AGEN
AGEN
FFWM
FFWM
Q4 25
0.0%
6.9%
Q3 25
0.0%
1.0%
Q2 25
0.0%
0.8%
Q1 25
0.0%
2.8%
Q4 24
0.3%
29.4%
Q3 24
0.0%
9.0%
Q2 24
2.0%
0.4%
Q1 24
0.1%
2.5%
Cash Conversion
AGEN
AGEN
FFWM
FFWM
Q4 25
Q3 25
-0.23×
Q2 25
Q1 25
-0.08×
Q4 24
Q3 24
Q2 24
-2.96×
Q1 24
9.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AGEN
AGEN

Non Cash Royalty Revenue$31.1M91%
Other$3.2M9%

FFWM
FFWM

Segment breakdown not available.

Related Comparisons